Introduction
A popliteal artery aneurysm (PAA) is a focal dilatation and weakening of the popliteal artery. PAA is the most frequently occurring peripheral aneurysm, accounting for 85 per cent 1, 2 . The majority of PAAs are degenerative in nature; 90 per cent occur in men, more than 50 per cent are bilateral, and over one-third of patients also have an abdominal aortic aneurysm (AAA) 3 . PAAs are typically asymptomatic. When symptomatic, they usually present with leg ischaemia from acute or chronic thrombosis, distal embolization or, rarely, rupture 4 .
Symptomatic PAAs of any size are treated by either surgical ligation combined with autologous vein bypass 5, 6 or by endoprosthesis 7 . Surgical treatment may be the preferred emergency intervention 8 .
Asymptomatic PAAs are treated to prevent the complications listed above. The main determinant for intervention is size. Above 20 mm in diameter the risk of complications provides the indication for treatment 9 . Some centres continue conservative management up to 30 mm 10 , and recommend intervention only for asymptomatic PAA larger than 30 mm 11 . With increasing size, the risk of complications from PAA increases, leading to potentially limb-threatening complications 10 .
Little work has been done to predict the progression of PAA, in contrast to AAA, where numerous studies have investigated growth rates 12, 13 . In AAA, growth rate depends on diameter 13 , which needs to be accounted for in a non-linear prediction model (simple growth/time analysis or linear regression).
One previous study 14 attempted to model expansion rates of asymptomatic PAA. Unfortunately, the value of the study is limited as it did not account for the lack of independence in observations (sequential measurements of the same PAA).
In this study, the progression of asymptomatic PAA in a single UK tertiary vascular centre was tracked over a 5-year interval. Several growth models were applied to these data, including simple growth/time analysis, linear regression and linear multilevel modelling (MLM).
Methods
Retrospective patient data were collected from a regional vascular unit serving a local population of more than 1 million patients. Patients were identified from arterial duplex scans performed between 1 January 2011 and 1 January 2016. Any patient who had a PAA on arterial duplex ultrasound imaging of the leg was included as long as they had two or more ultrasound scans of the limb. A PAA was defined as a popliteal artery with a diameter greater than 10 mm. Patients were excluded if they had undergone previous surgery or endovascular treatment for the PAA. All imaging data from the index scan until limb intervention or 1 January 2017 were included. If previous imaging of the lower limb was done before PAA diagnosis, data from this were also included.
Imaging
Patients were imaged in a relaxed lateral decubitus position by trained vascular scientists using an IU22 ultrasound scanner (Philips Healthcare Systems, Amsterdam, the Netherlands). Vessel size assessment measured the outer boundary wall to outer boundary wall specifically across the widest segment of the popliteal artery. Measurements were taken in both transverse and longitudinal sections with comparison to previous imaging available for reference. Imaging intervals were determined by the clinician in charge of the patient's care. Clinical data on the included patients were gathered from the hospital electronic medical records system. The primary outcome measured was PAA size, and the secondary outcome was progression to event or intervention.
Statistical analysis
Three statistical growth models were applied to the data: simple growth/time analysis, linear regression modelling and linear MLM. Statistical analysis was performed by a specialist biostatistician using the R environment (R Foundation for Statistical Computing, Vienna, Austria).
Growth/time analysis was done by calculating the difference between the first and last PAA diameters, and dividing this by the length of time between measurements. A linear regression model was fitted with popliteal artery diameter as the response element and time from the initial scan as the predictor. A parametric, linear multilevel model with two levels and measurements nested within patients was fitted by full maximum likelihood, with popliteal artery diameter as the response element and time from the initial scan as the fixed predictor. A random, normally distributed intercept term and a random, normally distributed slope term were added for each patient. Model comparisons were made using the Akaike Information Criterion (AIC) for the purposes of goodness-of-fit analysis. The AIC does not give information about the quality of the model itself, but makes it possible to compare them, and determine which model better represents the patient data. AIC rewards goodness-of-fit, and the preferred model has the lowest AIC value.
This study was approved by the NRES Committee East of England -Cambridge Central Research Ethics Committee (reference 17/EE/0326).
Results
Some 3217 lower-limb ultrasound records were screened; a total of 47 legs with PAA were identified in a cohort of 32 patients, 15 of whom had bilateral PAAs. There were 29 men and three women with a mean(s.d.) age of 74⋅6(8⋅3) years. The mean(s.d.) duration of surveillance was 3⋅71(2⋅59) years, and 174⋅2 cumulative years of data were collected. The mean(s.d.) PAA diameter at diagnosis was 16⋅0(7⋅1) mm. At diagnosis, 11 PAAs (23 per cent) were associated with detectable thrombus within the artery. Co-morbidities are listed in Table 1 .
Of the 47 limbs with a PAA under surveillance, one thrombosed acutely (this was managed conservatively) and ten (21 per cent) eventually proceeded to intervention, of which two were treated as an emergency. A total of 282 ultrasound images were used in the analysis of PAA growth; growth estimates were created using the three different modelling techniques. In the simple growth/time model, PAA growth was estimated at 11⋅7 (95 per cent c.i. 3⋅0 to 20⋅4) mm/year. In the linear regression model, PAA growth was estimated at 0⋅47 (0⋅14 to 0⋅81) mm/year (Fig. 1) . In the linear multilevel model, PAA growth was estimated at 2⋅4 (1⋅6 to 3⋅7) mm/year. Example individual patient trajectories using the linear multilevel model of PAA growth are shown in Fig. 2 .
The AIC could not be calculated for the growth/time model. For the linear regression model, the AIC was 907⋅9, and for the linear multilevel model it was 79⋅8.
A combined linear multilevel model was used to estimate PAA growth in patients with a known AAA and those without. Growth was estimated at 0⋅8 (95 per cent c.i. 0⋅1 to 1⋅5) mm/year in 12 patients without an AAA, compared with 3⋅5 (2⋅9 to 4⋅2) mm/year in 20 patients with a known AAA (P < 0⋅001). A full description of the model definition and results can be found in Appendices S1 and S2 (supporting information).
Discussion
This study modelled PAA growth in a cohort of 47 limbs. Concepts applied here have been used previously to study AAA modelling 13 .
The growth/time model produced an overestimate compared with the other models. This is likely due to the fact that the final scan triggered the intervention. This model also ignored a majority of the data points, as only 94 of the total 282 observations were used. The AIC was not applicable for this method and could not be calculated.
The linear regression model was also inaccurate due to the heterogeneity of individual growth trajectories. It did not take into account the multilevel structure of the data.
In the linear multilevel model, linear regression was modelled for each PAA before they were combined to provide an overall growth estimate; growth was higher than in the linear regression model.
The lower growth rate suggests that the multilevel model represents the data better. Using the linear MLM technique, the PAA growth rate in the cohort was 2⋅4 mm/year. This was similar to previous pooled estimates of AAA growth 13 .
When the multilevel model was applied using the presence of an AAA as a co-variable, there was a small difference between the growth estimate of the two groups, with those with an existing AAA exhibiting faster growth. The link between the presence of an AAA and faster PAA progression requires further dedicated study, but the present finding stresses the importance of identifying patients with a concomitant AAA, potentially to plan more regular surveillance.
Owing to the heterogeneous nature of PAA growth, surveillance intervals need to be tailored to individual patients based on other risk factors. Patient factors including sex, smoking status and diabetes are known to influence aneurysm growth and should be taken into account 12, 15 .
This study has several limitations. There was likely a degree of intraoperator variability as the measurements were performed by several operators. The precision of the measurements was also likely affected with the small millimetre measurements of the popliteal artery. In addition, the patient cohort was selected from a single centre, which affects the generalizability of the findings.
The overall sample size was small, which limits the ability to adjust for other co-variables including age, sex and co-morbidities. In addition, owing to the relatively short mean(s.d.) follow-up of 3⋅71(2⋅59) years, quadratic modelling, which would adjust for growth dependent on size, could not be done.
